Skip to main content
Top
Published in:

Open Access 10-03-2025 | Neuroblastoma | Case Report

Metastatic olfactory neuroblastoma with unusual solitary metastasis to femur: a case report and literature review

Authors: Abdulrahman Alaseem, Ahmed Altuwaim, Mishari Alanezi, Fahad Almehrij, Ibrahim Alshaygy, Saeed Bahabri, Motaz AlAqeel, Waleed Albishi

Published in: World Journal of Surgical Oncology | Issue 1/2025

Login to get access

Abstract

Background

Olfactory neuroblastoma (ONB) is a rare malignancy that develops in the nasal cavity, with appendicular skeletal metastases being exceptionally uncommon. We report the case of a middle-aged male with ONB, presenting with an unusual biopsy-confirmed solitary metastasis to the left proximal femur.

Case presentation

A 33-year-old male was previously diagnosed with olfactory neuroblastoma in the skull base after initial clinical presentation with progressive left-sided nasal obstruction for six months. He was treated with neoadjuvant chemotherapy, followed by local control via trans-sphenoidal resection in addition to postoperative radiotherapy and adjuvant chemotherapy. Two years later, the patient began experiencing left thigh pain. Radiographic imaging of the left femur revealed an ill-defined lesion in the midshaft with periosteal thickening, suggesting metastatic disease. The lesion caused significant bone destruction, ending up with a non-traumatic pathological fracture. A wide surgical resection of the proximal two-thirds of the femur was performed, followed by endoprosthetic reconstruction to restore structural integrity, joint function, and limb biomechanics. Postoperative management included physical rehabilitation to optimize functional recovery and maintain weight-bearing capacity.

Conclusion

This case underscores the importance of early identification of skeletal involvement in ONB, as prompt orthopedic intervention can prevent complications, improve mobility, and contribute to better oncological and functional outcomes. Advanced reconstructive techniques play a pivotal role in achieving durable results in cases involving skeletal metastasis of rare tumors like ONB.
Literature
8.
go back to reference Mori R, Sakai H, Kato M, Hida T, Nakajima M, Fukuda T, et al. Olfactory neuroblastoma with spinal metastasis: case report. No Shinkei Geka Neurol Surg. 2007;35:503–8. Mori R, Sakai H, Kato M, Hida T, Nakajima M, Fukuda T, et al. Olfactory neuroblastoma with spinal metastasis: case report. No Shinkei Geka Neurol Surg. 2007;35:503–8.
20.
go back to reference Broich G, Pagliari A, Ottaviani F. Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924. Anticancer Res. 1997;17:2683–706.PubMed Broich G, Pagliari A, Ottaviani F. Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924. Anticancer Res. 1997;17:2683–706.PubMed
Metadata
Title
Metastatic olfactory neuroblastoma with unusual solitary metastasis to femur: a case report and literature review
Authors
Abdulrahman Alaseem
Ahmed Altuwaim
Mishari Alanezi
Fahad Almehrij
Ibrahim Alshaygy
Saeed Bahabri
Motaz AlAqeel
Waleed Albishi
Publication date
10-03-2025
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2025
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-025-03727-z

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Incorporating comprehensive genomic profiling into the standard-of-care for NSCLC and thyroid cancer

In this interactive webinar, experts Dr. Subbiah, Dr. Drilon, and Dr. Williams discuss best pathological practices within NSCLC and thyroid cancer, as well as how genomic testing can improve outcomes in clinical practice, using patient case studies as illustrations.

This content is intended only for US-based healthcare providers.

Supported by:
  • Illumina, Inc., and Eli Lilly and Company
Dr. Vivek Subbiah
Dr. Alexander Drilon
Dr. Michelle Williams
Developed by: Springer Healthcare
Watch now
Video

Elevate your expertise in aplastic anemia (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Healthcare IME
Learn more